Teleflex Incorporated $TFX Stock: Royce & Associates LP Increases Holdings

Royce & Associates LP raised its holdings in Teleflex Incorporated (NYSE:TFX – Free Report) by 73.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 145,882 shares of the medical technology company’s stock after purchasing an additional 61,842 shares during the quarter. Royce & Associates LP owned 0.34% of Teleflex worth $18,241,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Teleflex during the 2nd quarter worth approximately $688,537,000. Jupiter Topco LLC acquired a new stake in shares of Teleflex in the 2nd quarter valued at approximately $550,456,000. Irenic Capital Management LP acquired a new stake in shares of Teleflex in the 1st quarter valued at approximately $104,061,000. Pzena Investment Management LLC purchased a new stake in shares of Teleflex in the second quarter valued at approximately $76,462,000. Finally, Bank of America Corp DE purchased a new stake in shares of Teleflex in the second quarter valued at approximately $61,156,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Wall Street Zen raised Teleflex from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. Royal Bank Of Canada raised their target price on Teleflex from $155.00 to $175.00 and gave the company an “outperform” rating in a report on Friday, November 6th. Mizuho set a $160.00 target price on Teleflex in a report on Friday, November 6th. Weiss Ratings upgraded shares of Teleflex from a “sell (d)” rating to a “hold (c)” rating in a research report on Monday, November 9th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $169.00 price target (up from $160.00) on shares of Teleflex in a research note on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $163.30.

Check Out Our Latest Stock Analysis on Teleflex

Teleflex Stock Performance

NYSE TFX opened at $155.00 on Monday. The business has a 50 day moving average price of $133.59 and a 200 day moving average price of $127.37. The company has a market capitalization of $6.15 billion, a P/E ratio of 18.83, a PEG ratio of 1.04 and a beta of 0.85. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $156.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.01 and a quick ratio of 1.59.

Teleflex (NYSE:TFX – Get Free Report) last posted its earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.73. The company had revenue of $567.80 million for the quarter, compared to the consensus estimate of $565.52 million. Teleflex had a return on equity of 10.57% and a net margin of 13.51%. Teleflex’s quarterly revenue was up .1% compared to the same quarter last year. During the same period in the previous year, the business earned $3.67 earnings per share. Sell-side analysts expect that Teleflex Incorporated will post 7.67 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 31st. Stockholders of record on Monday, November 16th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, November 16th. Teleflex’s payout ratio is 16.52%.

Teleflex Profile

(Free Report)

Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.

Recommended Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.